Poland· PL-100054257
Polfungicid
A imidazole/triazole in kombination mit corticosteroiden product containing chlormidazoli hydrochloridum + acidum salicylicum, registered in Poland by Bausch Health Ireland Ltd.. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Imidazole/triazole in kombination mit corticosteroiden is registered in 11 of 19 countries.
Countries holding a registration under ATC D01AC20 (imidazole/triazole in kombination mit corticosteroiden), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Imidazole/triazole in kombination mit corticosteroiden · ATC D01AC20
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Chlormidazoli hydrochloridum + Acidum salicylicum
- Manufacturer
- Bausch Health Ireland Ltd.
- Country
- Poland (PL)
- ATC code
- D01AC20
- ATC class
- Imidazole/Triazole in Kombination mit Corticosteroiden
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990232017
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under D01AC20
Imidazole/triazole in kombination mit corticosteroiden, as other registers publish it.
- FinlandAtlecortOrion Corporation Orion Pharma
- FinlandAtlecortOrion Corporation Orion Pharma
- DenmarkBrentacort2care4 ApS
- DenmarkBrentacortMcNeil Denmark ApS
- DenmarkBrentacortAbacus Medicine A/S
- DenmarkBrentacortEbb Medical AB
- IrelandCanesten HC 1% w/w + 1% w/w CreamBayer Limited
- IrelandCanesten HC CreamClotrimazole 1.0% w/w Hydrocortisone 1.0% w/wBayer Limited
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c3ec39ce-0c22-4d18-8bab-7c14ad2a2986 GET /v1/drugs/c3ec39ce-0c22-4d18-8bab-7c14ad2a2986?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór na skórę",
"source": "urpl",
"strength": "(50 mg + 10 mg)/ml",
"packaging": "05909990232017 ¦ OTC ¦ 61326\n1 butelka 10 ml",
"substance": "Chlormidazoli hydrochloridum 50 mg + Acidum salicylicum 10 mg",
"common_name": "Chlormidazoli hydrochloridum + Acidum salicylicum",
"pl_product_id": "100054257",
"pozwolenie_nr": "02320",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about imidazole/triazole in kombination mit corticosteroiden.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.